Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 3/2011

Content (15 Articles)

Original report

The use of mammographic tumour feature significantly improves outcome prediction of breast cancers smaller than 15 mm: a reproducibility study from two comprehensive breast centres

L. Tabár, L. Tucker, R. R. Davenport, J. G. Mullet, A. T. Hsiu-Hsi Chen, A. Ming-Fang Yen, S. Yueh-Hsia Chiu, J. Gladwell, K. Olinger, P. B. Dean

Short review

Molecular genetic tests in the prediction of the prognosis of breast cancer

F. R. Stoddard II, A. M. Szasz, B. Szekely, A.-M. Tokes, J. Kulka

Short review

Treatment of invasive fungal infections

R. Bellmann, S. Weiler

Short review

History of treatment and long-term outcome in children with acute lymphoblastic leukaemia in Serbia

D. Micic, B. Slavkovic, N. Rasovic Gvozdenovic, M. Kuzmanovic, L. Dokmanovic, N. Krstovski, D. Skoric, N. Konstantinidis, G. Kostic, J. Predojevic, D. Janic

Short review

History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia

S. Avcin, T. Prelog, M. Kavcic, L. Kitanovski, J. Anzic, M. Benedik Dolnicar, V. Rajic, L. Zadravec Zaletel, M. Debeljak, J. Jazbec

Short review

Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group

K. Derwich, J. Wachowiak, O. Zając-Spychała, A. Balcerska, W. Balwierz, A. Chybicka, J. R. Kowalczyk, M. Matysiak, T. Jackowska, D. Sońta-Jakimczyk, T. Szczepański, M. Wysocki

Short review

Results of acute lymphoblastic leukemia treatment in children in the Slovak Republic

E. Kaiserová, E. Bubánska, I. Oravkinová, Z. Šubová, A. Kolenová, A. Foltinová, J. Čáp

Short review

History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic

J. Starý, V. Mihál, P. Smíšek, B. Blažek, Y. Jabali, H. Hrstková, J. Hak, D. Procházková, Z. Černá, J. Štěrba, J. Trka, O. Hrušák, J. Zuna, E. Mejstříková, I. Janotová, P. Sedláček, H. Ptoszková, D. Pospíšilová, K. Toušovská, P. Timr, V. Vávra, K. Zdráhalová, L. Šrámková, Z. Zemanová, M. Jarošová, P. Gajdoš, O. Hrodek

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine